Literature DB >> 2792131

Effect of selenium supplementation on the distribution of selenium among plasma proteins of a patient with maple syrup urine disease.

M Borglund1, S Sjöblad, B Akesson.   

Abstract

Selenium (Se) status was studied in a patient with classical maple syrup urine disease (MSUD) receiving Se supplement. The basal plasma Se concentration was 0.06 mumol/l increasing to 2.1 mumol/l after 40 days of supplementation. When the plasma Se distribution was analysed by gel filtration, a major peak was seen close to the high molecular weight proteins with a second peak in the albumin region. When the Se dose was decreased in a stepwise manner from 50 micrograms/day to 25 micrograms/day and then to 17 micrograms/day plasma Se decreased, but the proportion of plasma Se in the two protein peaks did not change. In a healthy girl not supplemented with Se, the proportion of plasma Se in the albumin region was somewhat lower. In the MSUD patient glutathione peroxidase activity was initially low, and increased ten-fold during Se supplementation. The study indicates that the Se requirement for plasma glutathione peroxidase activity was fulfilled at the lowest dose of Se used and that Se is incorporated into several plasma proteins after supplementation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792131     DOI: 10.1007/bf00443107

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Selenium deficiency in total parenteral nutrition.

Authors:  A M van Rij; C D Thomson; J M McKenzie; M F Robinson
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

2.  Effect of selenium supplementation on the distribution of selenium in plasma proteins of healthy subjects.

Authors:  M Borglund; B Akesson
Journal:  Int J Vitam Nutr Res       Date:  1988       Impact factor: 1.784

3.  Plasma selenium levels in treated phenylketonuric patients.

Authors:  A Rottoli; G Lista; G Zecchini; C Butté; R Longhi
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  Keshan disease and selenium in China.

Authors: 
Journal:  Curr Concepts Nutr       Date:  1982

5.  An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood.

Authors:  W A Günzler; H Kremers; L Flohé
Journal:  Z Klin Chem Klin Biochem       Date:  1974-10

6.  Selenium requirements in patients with inborn errors of amino acid metabolism and selenium deficiency.

Authors:  I Lombeck; K Kasperek; D Bachmann; L E Feinendegen; H J Bremer
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

7.  Distribution of selenium and glutathione peroxidase in blood fractions from humans, rhesus and squirrel monkeys, rats and sheep.

Authors:  M A Beilstein; P D Whanger
Journal:  J Nutr       Date:  1983-11       Impact factor: 4.798

8.  Abundance and tissue distribution of selenocysteine-containing proteins in the rat.

Authors:  W C Hawkes; E C Wilhelmsen; A L Tappel
Journal:  J Inorg Biochem       Date:  1985-02       Impact factor: 4.155

9.  Selenium intake of infants and young children, healthy children and dietetically treated patients with phenylketonuria.

Authors:  I Lombeck; K H Ebert; K Kasperek; L E Feinendegen; H J Bremer
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

10.  Selenium, alcohol and liver diseases.

Authors:  J Aaseth; A Smith-Kielland; Y Thomassen
Journal:  Ann Clin Res       Date:  1986
View more
  2 in total

1.  Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.

Authors:  Luciane Taschetto; Giselli Scaini; Hugo G Zapelini; Ândrea C Ramos; Giulia Strapazzon; Vanessa M Andrade; Gislaine Z Réus; Monique Michels; Felipe Dal-Pizzol; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-05-27       Impact factor: 3.584

Review 2.  Neurological damage in MSUD: the role of oxidative stress.

Authors:  Angela Sitta; Graziela S Ribas; Caroline P Mescka; Alethéa G Barschak; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2013-11-13       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.